NeuroKaire
Pre-clinicalNeuroKaire (formerly GenetikaPlus) is pioneering a personalized treatment approach for psychiatric and neurological conditions, transforming the way these diseases are treated and new drugs are discovered.
Founded
2021
Focus
Diagnostics
About
NeuroKaire (formerly GenetikaPlus) is pioneering a personalized treatment approach for psychiatric and neurological conditions, transforming the way these diseases are treated and new drugs are discovered.
Funding History
2Total raised: $15M
Series A$12MUndisclosedApr 15, 2022
Seed$3MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2021
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile